A bioactivity-leveling approach for component-specific evaluation in natural product extracts: Optimizing SARS-CoV-2 antiviral screening by controlling for pheophorbide A

Corinna Urmann, Yvonne Gmach, Niklas Hofer, Nina Vahekeni, Jonas Stehlin, Yannick Geissmann, Andreas Lardos, Olivier Engler · 2026

Read A bioactivity-leveling approach for component-specific evaluation in natural product extracts: Optimizing SARS-CoV-2 antiviral screening by controlling for pheophorbide A by Corinna Urmann, Yvonne Gmach, Niklas Hofer, Nina Vahekeni, Jonas Stehlin, Yannick Geissmann, Andreas Lardos, Olivier Engler (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355466.txt.

Description

Corinna Urmann and colleagues tackled a classic trap in hunting antiviral compounds in plants. One common chlorophyll breakdown product, pheophorbide A, blocks viruses so reliably that it drowns out every subtler candidate in a screening test. Their 2026 study built a leveling strategy. It measured each extract's pheophorbide content. It judged the extract's antiviral effect against what that content alone predicts.

Six of fifteen plant species cleared the bar and earned priority for deeper work. In cowslip fractions, the comparison plus chemical profiling pointed to additional candidate molecules beyond the usual suspect. The method generalizes. Any natural product screen haunted by one dominant compound can use the same accounting trick to find the quieter chemistry hiding behind it.

Catalog record

CREATORCorinna Urmann, Yvonne Gmach, Niklas Hofer, Nina Vahekeni, Jonas Stehlin, Yannick Geissmann, Andreas Lardos, Olivier Engler
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51659
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0355466

Browse the full library · About the Tower of Babel